Market Outlook
The global Organ-On-Chip market size was valued at USD 62 million in 2022 and is forecast to a readjusted size of USD 424.8 million by 2029 with a CAGR of 31.6% during review period.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
This report is a detailed and comprehensive analysis for global Organ-On-Chip market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Organ-On-Chip market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ-On-Chip market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ-On-Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ-On-Chip market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Organ-On-Chip
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Organ-On-Chip market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Emulate
Mimetas
TissUse
Tara Biosystems
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
Beijing Daxiang Biotech
Segmentation By Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Others
Segmentation By Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Organ-On-Chip market in 2025?
The Organ-On-Chip market benefits from advanced technology that allows for accurate human cell modeling, providing more reliable preclinical testing for drugs and diseases. This technology reduces the need for animal testing, which is ethically favorable and increasingly regulated. Its growing integration into pharmaceutical R&D makes it an essential tool for developing personalized medicine.
What are the weaknesses of the Organ-On-Chip market in 2025?
Despite its potential, the Organ-On-Chip market faces challenges in terms of scalability and complexity. The technology is still evolving, and there may be limitations in replicating the full complexity of human organs. Additionally, there are high initial costs for development and a lack of standardized models, which can hinder widespread adoption.
What are the opportunities in the Organ-On-Chip market in 2025?
The market holds vast potential in drug discovery, toxicity testing, and personalized medicine. As regulatory bodies move toward supporting more ethical testing alternatives, Organ-On-Chip solutions can become integral in meeting these demands. The expansion of biotech and pharma industries worldwide also presents new opportunities for collaboration and commercialization of these systems.
What are the threats to the Organ-On-Chip market in 2025?
The market could face competition from alternative technologies such as 3D cell cultures and AI-driven drug discovery platforms. Intellectual property concerns and the slow pace of regulatory approvals may also present barriers to faster market growth. Additionally, the market may struggle with the integration of such technologies into existing pharmaceutical and healthcare systems.
Market PESTEL Analysis
What are the political factors affecting the Organ-On-Chip market in 2025?
Political factors such as government regulations on animal testing and ethical standards in scientific research significantly influence the Organ-On-Chip market. As governments continue to push for alternatives to animal testing, Organ-On-Chip technologies are increasingly supported. However, any changes in regulatory policies or funding priorities can impact the market's growth.
What are the economic factors affecting the Organ-On-Chip market in 2025?
Economic factors like the global demand for cost-effective drug development processes and research funding can drive the market. Organ-On-Chip technologies offer cost savings by reducing reliance on animal testing and improving the accuracy of preclinical trials, which can attract investment from pharmaceutical companies. Economic downturns, however, may reduce R&D budgets, hindering market expansion.
What are the social factors affecting the Organ-On-Chip market in 2025?
Social factors include the growing demand for more ethical and humane alternatives in scientific research, which boosts the appeal of Organ-On-Chip technologies. Public awareness of animal testing issues and the benefits of personalized medicine also support market growth. However, skepticism and lack of understanding of these new technologies may slow adoption in certain populations.
What are the technological factors affecting the Organ-On-Chip market in 2025?
Technological advancements in microfluidics, cell biology, and materials science play a key role in the development of Organ-On-Chip devices. The market is propelled by continuous innovations that improve the accuracy, scalability, and functionality of these systems. However, the technology is still maturing, and challenges in replicating complex human organ systems limit its full potential.
What are the environmental factors affecting the Organ-On-Chip market in 2025?
Environmental factors, such as growing concerns over sustainability and the reduction of animal testing, have a positive impact on the market. Organ-On-Chip technologies help reduce the environmental footprint associated with animal testing. However, the environmental impact of manufacturing these complex systems and the disposal of electronic components may raise concerns.
What are the legal factors affecting the Organ-On-Chip market in 2025?
Legal factors include the evolving regulatory frameworks surrounding new medical technologies, particularly in drug testing and clinical trials. Regulatory approval for Organ-On-Chip devices must be carefully navigated, as inconsistent standards across regions can delay market entry. Intellectual property rights and patent disputes could also affect the competitiveness and innovation within the market.
Market SIPOC Analysis
What are the suppliers in the Organ-On-Chip market in 2025?
Suppliers in the Organ-On-Chip market include companies providing raw materials like microfluidic devices, biocompatible materials, and cell culture systems. Additionally, suppliers of high-tech equipment for manufacturing and research, as well as firms offering specialized software for simulation and analysis, are critical to the market.
What are the inputs in the Organ-On-Chip market in 2025?
Inputs to the Organ-On-Chip market include human cells or stem cells, biological data, microfluidic chips, lab equipment, research funding, and the technical expertise required to design, produce, and validate the systems. Regulatory guidelines and ethical standards also serve as important inputs for product development.
What are the processes in the Organ-On-Chip market in 2025?
Processes in this market involve research and development of new organ models, manufacturing of the chips, testing of drug efficacy and toxicity, and data collection for regulatory approval. Validating the performance of these models in preclinical trials and integrating them into pharmaceutical workflows are key processes that drive the market forward.
What are the outputs in the Organ-On-Chip market in 2025?
Outputs of the Organ-On-Chip market include advanced organ models for drug testing, disease modeling, and personalized medicine applications. These outputs contribute to reducing the use of animal testing, accelerating drug discovery, and providing more accurate and efficient tools for pharmaceutical research and development.
What are the customers in the Organ-On-Chip market in 2025?
Customers in the Organ-On-Chip market include pharmaceutical companies, biotechnology firms, academic and research institutions, regulatory bodies, and healthcare providers. Additionally, contract research organizations (CROs) and environmental testing agencies are also key customers seeking innovative and ethical testing alternatives.
Market Porter's Five Forces
What is the threat of new entrants in the Organ-On-Chip market in 2025?
The threat of new entrants is moderate in the Organ-On-Chip market due to the high technical expertise required and significant capital investment in research and development. However, as the technology matures and becomes more standardized, new players with innovative approaches may still enter the market, potentially increasing competition.
What is the bargaining power of suppliers in the Organ-On-Chip market in 2025?
The bargaining power of suppliers is moderate to high, as specialized materials, equipment, and technology are essential for the development of Organ-On-Chip systems. However, as the market grows and more suppliers enter the market, the power may shift more toward manufacturers and developers.
What is the bargaining power of buyers in the Organ-On-Chip market in 2025?
The bargaining power of buyers is moderate, as pharmaceutical companies, academic institutions, and healthcare providers seek reliable, cost-effective solutions. The limited number of advanced Organ-On-Chip systems may give suppliers more control, but buyers can influence pricing and innovation through their purchasing decisions.
What is the threat of substitute products or services in the Organ-On-Chip market in 2025?
The threat of substitutes is moderate, as alternatives such as 3D cell cultures, AI-driven drug discovery platforms, and traditional animal testing may still be preferred in some cases. However, the unique advantages of Organ-On-Chip systems, such as reducing ethical concerns and improving accuracy, make them a strong contender for widespread adoption.
What is the intensity of competitive rivalry in the Organ-On-Chip market in 2025?
The intensity of competitive rivalry is expected to be moderate to high, as more companies and research institutions invest in Organ-On-Chip technologies. While the market is still emerging, the competition for innovation, intellectual property, and market share is likely to intensify as the technology matures and becomes more integrated into pharmaceutical research processes.
Market Upstream Analysis
What are the key inputs required in the Organ-On-Chip market in 2025?
Key inputs include human cells or stem cells, advanced materials for chip fabrication (e.g., polymers, glass), microfluidic technology components, biocompatible substances, and laboratory equipment. Additionally, software for data analysis, modeling, and simulation is critical in the development and validation of the systems.
What are the primary suppliers in the Organ-On-Chip market in 2025?
Primary suppliers include companies specializing in microfluidic device manufacturing, biotechnological firms providing human cells and stem cells, materials suppliers for biocompatible substances, and equipment suppliers for laboratory testing. Software developers also play a crucial role in providing platforms for simulation and data interpretation.
What are the production challenges in the Organ-On-Chip market in 2025?
Production challenges include scaling up the technology while maintaining the accuracy and reliability of the chips. Ensuring that the organ models replicate human organ behavior and functionality can be technically demanding. Additionally, high production costs and ensuring quality control across different models present challenges in meeting market demands.
What are the research and development requirements in the Organ-On-Chip market in 2025?
R&D requirements involve advancing the understanding of human biology, improving microfluidic chip designs, and enhancing the scalability and reproducibility of these systems. Collaboration between academic institutions, biotechnological firms, and regulatory bodies is also crucial to drive innovation and ensure compliance with ethical standards and regulatory requirements.
What role does regulation play in the upstream of the Organ-On-Chip market in 2025?
Regulation plays a significant role in defining the standards for product development, safety, and efficacy. Compliance with regulatory requirements for preclinical testing, drug development, and ethical concerns regarding human cells is essential. Regulatory frameworks can either drive innovation by promoting alternatives to animal testing or slow down the process with stringent guidelines.
Market Midstream Analysis
What are the key activities in the midstream of the Organ-On-Chip market in 2025?
Key activities in the midstream include the manufacturing and assembly of Organ-On-Chip devices, integration of microfluidic systems with human cells, and the validation of the chips in research and preclinical environments. This stage also involves the refinement of technology for improved accuracy in drug testing, disease modeling, and personalized medicine applications.
What are the challenges in the midstream of the Organ-On-Chip market in 2025?
Challenges include ensuring the reproducibility and scalability of Organ-On-Chip systems while maintaining their complexity and accuracy. There are also issues with standardization across various platforms, which could impact the integration of the technology into pharmaceutical and clinical workflows. Additionally, managing the technical complexity of integrating biological and mechanical systems remains a challenge.
What is the role of partnerships and collaborations in the midstream of the Organ-On-Chip market in 2025?
Partnerships and collaborations between pharmaceutical companies, academic institutions, and biotech firms are crucial in advancing the development and adoption of Organ-On-Chip technologies. These collaborations help to pool resources, share expertise, and navigate regulatory challenges. They also enable the testing of Organ-On-Chip systems in real-world scenarios, further enhancing their credibility and acceptance in the market.
What are the production and operational considerations in the midstream of the Organ-On-Chip market in 2025?
Production and operational considerations include ensuring a seamless manufacturing process for chips that can reliably simulate human organ functions. This involves maintaining stringent quality control, optimizing the use of raw materials, and minimizing waste during production. Efficient supply chain management and the integration of new technologies to support scalable production are also key factors in this stage.
What is the market acceptance and adoption status of Organ-On-Chip technologies in 2025?
The market acceptance of Organ-On-Chip technologies is growing, particularly within pharmaceutical and biotech sectors, where there is an increasing demand for alternative drug testing methods. However, adoption is still slow in broader clinical applications, and standardization remains a barrier. Efforts to demonstrate the value of these systems in accelerating drug development and reducing animal testing will drive further adoption.
Market Downstream Analysis
What are the key activities in the downstream of the Organ-On-Chip market in 2025?
Key activities in the downstream include the application of Organ-On-Chip devices in drug testing, toxicity studies, personalized medicine, and disease modeling. These systems are also used for regulatory compliance testing and by pharmaceutical companies to speed up preclinical trials and make more informed decisions during drug development.
What are the challenges in the downstream of the Organ-On-Chip market in 2025?
Challenges include the slow integration of Organ-On-Chip technology into established pharmaceutical R&D pipelines. The lack of standardization in models and inconsistent regulatory approvals can also limit widespread adoption. Additionally, the high cost of these systems may deter some smaller pharmaceutical firms or research institutions from utilizing them.
What is the role of end-users in the downstream of the Organ-On-Chip market in 2025?
End-users, such as pharmaceutical companies, academic researchers, contract research organizations (CROs), and regulatory agencies, are critical in driving the demand for Organ-On-Chip technology. Their feedback, collaboration, and application of the technology in real-world settings help refine and improve the devices, leading to better market penetration.
What are the distribution channels in the downstream of the Organ-On-Chip market in 2025?
Distribution channels include direct sales by manufacturers to pharmaceutical and biotech companies, research institutions, and academic labs. Online platforms, specialized scientific suppliers, and partnerships with contract research organizations (CROs) also play an important role in distributing Organ-On-Chip systems to end-users.
What is the market adoption status in the downstream of the Organ-On-Chip market in 2025?
Market adoption is growing, particularly within large pharmaceutical companies and research institutions, which are increasingly using Organ-On-Chip systems for drug development and testing. However, adoption in smaller firms and clinical settings remains slower due to the high initial costs and the need for extensive validation. As the technology becomes more proven and accessible, broader adoption is expected.
Chapter 1, to describe Organ-On-Chip product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Organ-On-Chip, with price, sales, revenue and global market share of Organ-On-Chip from 2018 to 2023.
Chapter 3, the Organ-On-Chip competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Organ-On-Chip breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Organ-On-Chip market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Organ-On-Chip.
Chapter 14 and 15, to describe Organ-On-Chip sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Organ-On-Chip
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Organ-On-Chip Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Brain-on-a-chip
1.3.3 Liver-on-a-chip
1.3.4 Kidney-on-a-chip
1.3.5 Lung-on-a-chip
1.3.6 Heart-on-a-chip
1.3.7 Intestine-on-a-chip
1.3.8 Vessel-on-a-chip
1.3.9 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Organ-On-Chip Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Academic & Research Institutes
1.4.4 Cosmetics Industry
1.4.5 Others
1.5 Global Organ-On-Chip Market Size & Forecast
1.5.1 Global Organ-On-Chip Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Organ-On-Chip Sales Quantity (2018-2029)
1.5.3 Global Organ-On-Chip Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Organ-On-Chip Product and Services
2.1.4 Emulate Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Emulate Recent Developments/Updates
2.2 Mimetas
2.2.1 Mimetas Details
2.2.2 Mimetas Major Business
2.2.3 Mimetas Organ-On-Chip Product and Services
2.2.4 Mimetas Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mimetas Recent Developments/Updates
2.3 TissUse
2.3.1 TissUse Details
2.3.2 TissUse Major Business
2.3.3 TissUse Organ-On-Chip Product and Services
2.3.4 TissUse Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TissUse Recent Developments/Updates
2.4 Tara Biosystems
2.4.1 Tara Biosystems Details
2.4.2 Tara Biosystems Major Business
2.4.3 Tara Biosystems Organ-On-Chip Product and Services
2.4.4 Tara Biosystems Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tara Biosystems Recent Developments/Updates
2.5 CN Bio Innovations
2.5.1 CN Bio Innovations Details
2.5.2 CN Bio Innovations Major Business
2.5.3 CN Bio Innovations Organ-On-Chip Product and Services
2.5.4 CN Bio Innovations Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CN Bio Innovations Recent Developments/Updates
2.6 Hesperos
2.6.1 Hesperos Details
2.6.2 Hesperos Major Business
2.6.3 Hesperos Organ-On-Chip Product and Services
2.6.4 Hesperos Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hesperos Recent Developments/Updates
2.7 Draper Laboratory
2.7.1 Draper Laboratory Details
2.7.2 Draper Laboratory Major Business
2.7.3 Draper Laboratory Organ-On-Chip Product and Services
2.7.4 Draper Laboratory Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Draper Laboratory Recent Developments/Updates
2.8 Nortis
2.8.1 Nortis Details
2.8.2 Nortis Major Business
2.8.3 Nortis Organ-On-Chip Product and Services
2.8.4 Nortis Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nortis Recent Developments/Updates
2.9 Micronit Microtechnologies B.V.
2.9.1 Micronit Microtechnologies B.V. Details
2.9.2 Micronit Microtechnologies B.V. Major Business
2.9.3 Micronit Microtechnologies B.V. Organ-On-Chip Product and Services
2.9.4 Micronit Microtechnologies B.V. Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
2.10 Kirkstall
2.10.1 Kirkstall Details
2.10.2 Kirkstall Major Business
2.10.3 Kirkstall Organ-On-Chip Product and Services
2.10.4 Kirkstall Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Kirkstall Recent Developments/Updates
2.11 Cherry Biotech SAS
2.11.1 Cherry Biotech SAS Details
2.11.2 Cherry Biotech SAS Major Business
2.11.3 Cherry Biotech SAS Organ-On-Chip Product and Services
2.11.4 Cherry Biotech SAS Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cherry Biotech SAS Recent Developments/Updates
2.12 Else Kooi Laboratory
2.12.1 Else Kooi Laboratory Details
2.12.2 Else Kooi Laboratory Major Business
2.12.3 Else Kooi Laboratory Organ-On-Chip Product and Services
2.12.4 Else Kooi Laboratory Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Else Kooi Laboratory Recent Developments/Updates
2.13 Altis Biosystems
2.13.1 Altis Biosystems Details
2.13.2 Altis Biosystems Major Business
2.13.3 Altis Biosystems Organ-On-Chip Product and Services
2.13.4 Altis Biosystems Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Altis Biosystems Recent Developments/Updates
2.14 Bi/ond
2.14.1 Bi/ond Details
2.14.2 Bi/ond Major Business
2.14.3 Bi/ond Organ-On-Chip Product and Services
2.14.4 Bi/ond Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bi/ond Recent Developments/Updates
2.15 Netri
2.15.1 Netri Details
2.15.2 Netri Major Business
2.15.3 Netri Organ-On-Chip Product and Services
2.15.4 Netri Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Netri Recent Developments/Updates
2.16 Xona Microfluidics
2.16.1 Xona Microfluidics Details
2.16.2 Xona Microfluidics Major Business
2.16.3 Xona Microfluidics Organ-On-Chip Product and Services
2.16.4 Xona Microfluidics Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Xona Microfluidics Recent Developments/Updates
2.17 Beijing Daxiang Biotech
2.17.1 Beijing Daxiang Biotech Details
2.17.2 Beijing Daxiang Biotech Major Business
2.17.3 Beijing Daxiang Biotech Organ-On-Chip Product and Services
2.17.4 Beijing Daxiang Biotech Organ-On-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Beijing Daxiang Biotech Recent Developments/Updates
3 Competitive Environment: Organ-On-Chip by Manufacturer
3.1 Global Organ-On-Chip Sales Quantity by Manufacturer (2018-2023)
3.2 Global Organ-On-Chip Revenue by Manufacturer (2018-2023)
3.3 Global Organ-On-Chip Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Organ-On-Chip by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Organ-On-Chip Manufacturer Market Share in 2022
3.4.2 Top 6 Organ-On-Chip Manufacturer Market Share in 2022
3.5 Organ-On-Chip Market: Overall Company Footprint Analysis
3.5.1 Organ-On-Chip Market: Region Footprint
3.5.2 Organ-On-Chip Market: Company Product Type Footprint
3.5.3 Organ-On-Chip Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Organ-On-Chip Market Size by Region
4.1.1 Global Organ-On-Chip Sales Quantity by Region (2018-2029)
4.1.2 Global Organ-On-Chip Consumption Value by Region (2018-2029)
4.1.3 Global Organ-On-Chip Average Price by Region (2018-2029)
4.2 North America Organ-On-Chip Consumption Value (2018-2029)
4.3 Europe Organ-On-Chip Consumption Value (2018-2029)
4.4 Asia-Pacific Organ-On-Chip Consumption Value (2018-2029)
4.5 South America Organ-On-Chip Consumption Value (2018-2029)
4.6 Middle East and Africa Organ-On-Chip Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Organ-On-Chip Sales Quantity by Type (2018-2029)
5.2 Global Organ-On-Chip Consumption Value by Type (2018-2029)
5.3 Global Organ-On-Chip Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Organ-On-Chip Sales Quantity by Application (2018-2029)
6.2 Global Organ-On-Chip Consumption Value by Application (2018-2029)
6.3 Global Organ-On-Chip Average Price by Application (2018-2029)
7 North America
7.1 North America Organ-On-Chip Sales Quantity by Type (2018-2029)
7.2 North America Organ-On-Chip Sales Quantity by Application (2018-2029)
7.3 North America Organ-On-Chip Market Size by Country
7.3.1 North America Organ-On-Chip Sales Quantity by Country (2018-2029)
7.3.2 North America Organ-On-Chip Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Organ-On-Chip Sales Quantity by Type (2018-2029)
8.2 Europe Organ-On-Chip Sales Quantity by Application (2018-2029)
8.3 Europe Organ-On-Chip Market Size by Country
8.3.1 Europe Organ-On-Chip Sales Quantity by Country (2018-2029)
8.3.2 Europe Organ-On-Chip Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Organ-On-Chip Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Organ-On-Chip Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Organ-On-Chip Market Size by Region
9.3.1 Asia-Pacific Organ-On-Chip Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Organ-On-Chip Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Organ-On-Chip Sales Quantity by Type (2018-2029)
10.2 South America Organ-On-Chip Sales Quantity by Application (2018-2029)
10.3 South America Organ-On-Chip Market Size by Country
10.3.1 South America Organ-On-Chip Sales Quantity by Country (2018-2029)
10.3.2 South America Organ-On-Chip Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Organ-On-Chip Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Organ-On-Chip Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Organ-On-Chip Market Size by Country
11.3.1 Middle East & Africa Organ-On-Chip Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Organ-On-Chip Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Organ-On-Chip Market Drivers
12.2 Organ-On-Chip Market Restraints
12.3 Organ-On-Chip Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Organ-On-Chip and Key Manufacturers
13.2 Manufacturing Costs Percentage of Organ-On-Chip
13.3 Organ-On-Chip Production Process
13.4 Organ-On-Chip Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Organ-On-Chip Typical Distributors
14.3 Organ-On-Chip Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Organ-On-Chip Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Organ-On-Chip Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Emulate Basic Information, Manufacturing Base and Competitors
Table 4. Emulate Major Business
Table 5. Emulate Organ-On-Chip Product and Services
Table 6. Emulate Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Emulate Recent Developments/Updates
Table 8. Mimetas Basic Information, Manufacturing Base and Competitors
Table 9. Mimetas Major Business
Table 10. Mimetas Organ-On-Chip Product and Services
Table 11. Mimetas Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mimetas Recent Developments/Updates
Table 13. TissUse Basic Information, Manufacturing Base and Competitors
Table 14. TissUse Major Business
Table 15. TissUse Organ-On-Chip Product and Services
Table 16. TissUse Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. TissUse Recent Developments/Updates
Table 18. Tara Biosystems Basic Information, Manufacturing Base and Competitors
Table 19. Tara Biosystems Major Business
Table 20. Tara Biosystems Organ-On-Chip Product and Services
Table 21. Tara Biosystems Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tara Biosystems Recent Developments/Updates
Table 23. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 24. CN Bio Innovations Major Business
Table 25. CN Bio Innovations Organ-On-Chip Product and Services
Table 26. CN Bio Innovations Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CN Bio Innovations Recent Developments/Updates
Table 28. Hesperos Basic Information, Manufacturing Base and Competitors
Table 29. Hesperos Major Business
Table 30. Hesperos Organ-On-Chip Product and Services
Table 31. Hesperos Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hesperos Recent Developments/Updates
Table 33. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 34. Draper Laboratory Major Business
Table 35. Draper Laboratory Organ-On-Chip Product and Services
Table 36. Draper Laboratory Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Draper Laboratory Recent Developments/Updates
Table 38. Nortis Basic Information, Manufacturing Base and Competitors
Table 39. Nortis Major Business
Table 40. Nortis Organ-On-Chip Product and Services
Table 41. Nortis Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Nortis Recent Developments/Updates
Table 43. Micronit Microtechnologies B.V. Basic Information, Manufacturing Base and Competitors
Table 44. Micronit Microtechnologies B.V. Major Business
Table 45. Micronit Microtechnologies B.V. Organ-On-Chip Product and Services
Table 46. Micronit Microtechnologies B.V. Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Micronit Microtechnologies B.V. Recent Developments/Updates
Table 48. Kirkstall Basic Information, Manufacturing Base and Competitors
Table 49. Kirkstall Major Business
Table 50. Kirkstall Organ-On-Chip Product and Services
Table 51. Kirkstall Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Kirkstall Recent Developments/Updates
Table 53. Cherry Biotech SAS Basic Information, Manufacturing Base and Competitors
Table 54. Cherry Biotech SAS Major Business
Table 55. Cherry Biotech SAS Organ-On-Chip Product and Services
Table 56. Cherry Biotech SAS Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cherry Biotech SAS Recent Developments/Updates
Table 58. Else Kooi Laboratory Basic Information, Manufacturing Base and Competitors
Table 59. Else Kooi Laboratory Major Business
Table 60. Else Kooi Laboratory Organ-On-Chip Product and Services
Table 61. Else Kooi Laboratory Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Else Kooi Laboratory Recent Developments/Updates
Table 63. Altis Biosystems Basic Information, Manufacturing Base and Competitors
Table 64. Altis Biosystems Major Business
Table 65. Altis Biosystems Organ-On-Chip Product and Services
Table 66. Altis Biosystems Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Altis Biosystems Recent Developments/Updates
Table 68. Bi/ond Basic Information, Manufacturing Base and Competitors
Table 69. Bi/ond Major Business
Table 70. Bi/ond Organ-On-Chip Product and Services
Table 71. Bi/ond Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bi/ond Recent Developments/Updates
Table 73. Netri Basic Information, Manufacturing Base and Competitors
Table 74. Netri Major Business
Table 75. Netri Organ-On-Chip Product and Services
Table 76. Netri Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Netri Recent Developments/Updates
Table 78. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
Table 79. Xona Microfluidics Major Business
Table 80. Xona Microfluidics Organ-On-Chip Product and Services
Table 81. Xona Microfluidics Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Xona Microfluidics Recent Developments/Updates
Table 83. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Beijing Daxiang Biotech Major Business
Table 85. Beijing Daxiang Biotech Organ-On-Chip Product and Services
Table 86. Beijing Daxiang Biotech Organ-On-Chip Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Beijing Daxiang Biotech Recent Developments/Updates
Table 88. Global Organ-On-Chip Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 89. Global Organ-On-Chip Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Organ-On-Chip Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in Organ-On-Chip, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Organ-On-Chip Production Site of Key Manufacturer
Table 93. Organ-On-Chip Market: Company Product Type Footprint
Table 94. Organ-On-Chip Market: Company Product Application Footprint
Table 95. Organ-On-Chip New Market Entrants and Barriers to Market Entry
Table 96. Organ-On-Chip Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Organ-On-Chip Sales Quantity by Region (2018-2023) & (K Units)
Table 98. Global Organ-On-Chip Sales Quantity by Region (2024-2029) & (K Units)
Table 99. Global Organ-On-Chip Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Organ-On-Chip Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Organ-On-Chip Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global Organ-On-Chip Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global Organ-On-Chip Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Global Organ-On-Chip Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Global Organ-On-Chip Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Organ-On-Chip Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Organ-On-Chip Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global Organ-On-Chip Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global Organ-On-Chip Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Global Organ-On-Chip Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Global Organ-On-Chip Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Organ-On-Chip Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Organ-On-Chip Average Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Organ-On-Chip Average Price by Application (2024-2029) & (US$/Unit)
Table 115. North America Organ-On-Chip Sales Quantity by Type (2018-2023) & (K Units)
Table 116. North America Organ-On-Chip Sales Quantity by Type (2024-2029) & (K Units)
Table 117. North America Organ-On-Chip Sales Quantity by Application (2018-2023) & (K Units)
Table 118. North America Organ-On-Chip Sales Quantity by Application (2024-2029) & (K Units)
Table 119. North America Organ-On-Chip Sales Quantity by Country (2018-2023) & (K Units)
Table 120. North America Organ-On-Chip Sales Quantity by Country (2024-2029) & (K Units)
Table 121. North America Organ-On-Chip Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Organ-On-Chip Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Organ-On-Chip Sales Quantity by Type (2018-2023) & (K Units)
Table 124. Europe Organ-On-Chip Sales Quantity by Type (2024-2029) & (K Units)
Table 125. Europe Organ-On-Chip Sales Quantity by Application (2018-2023) & (K Units)
Table 126. Europe Organ-On-Chip Sales Quantity by Application (2024-2029) & (K Units)
Table 127. Europe Organ-On-Chip Sales Quantity by Country (2018-2023) & (K Units)
Table 128. Europe Organ-On-Chip Sales Quantity by Country (2024-2029) & (K Units)
Table 129. Europe Organ-On-Chip Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Organ-On-Chip Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Organ-On-Chip Sales Quantity by Type (2018-2023) & (K Units)
Table 132. Asia-Pacific Organ-On-Chip Sales Quantity by Type (2024-2029) & (K Units)
Table 133. Asia-Pacific Organ-On-Chip Sales Quantity by Application (2018-2023) & (K Units)
Table 134. Asia-Pacific Organ-On-Chip Sales Quantity by Application (2024-2029) & (K Units)
Table 135. Asia-Pacific Organ-On-Chip Sales Quantity by Region (2018-2023) & (K Units)
Table 136. Asia-Pacific Organ-On-Chip Sales Quantity by Region (2024-2029) & (K Units)
Table 137. Asia-Pacific Organ-On-Chip Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Organ-On-Chip Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Organ-On-Chip Sales Quantity by Type (2018-2023) & (K Units)
Table 140. South America Organ-On-Chip Sales Quantity by Type (2024-2029) & (K Units)
Table 141. South America Organ-On-Chip Sales Quantity by Application (2018-2023) & (K Units)
Table 142. South America Organ-On-Chip Sales Quantity by Application (2024-2029) & (K Units)
Table 143. South America Organ-On-Chip Sales Quantity by Country (2018-2023) & (K Units)
Table 144. South America Organ-On-Chip Sales Quantity by Country (2024-2029) & (K Units)
Table 145. South America Organ-On-Chip Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Organ-On-Chip Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Organ-On-Chip Sales Quantity by Type (2018-2023) & (K Units)
Table 148. Middle East & Africa Organ-On-Chip Sales Quantity by Type (2024-2029) & (K Units)
Table 149. Middle East & Africa Organ-On-Chip Sales Quantity by Application (2018-2023) & (K Units)
Table 150. Middle East & Africa Organ-On-Chip Sales Quantity by Application (2024-2029) & (K Units)
Table 151. Middle East & Africa Organ-On-Chip Sales Quantity by Region (2018-2023) & (K Units)
Table 152. Middle East & Africa Organ-On-Chip Sales Quantity by Region (2024-2029) & (K Units)
Table 153. Middle East & Africa Organ-On-Chip Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Organ-On-Chip Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Organ-On-Chip Raw Material
Table 156. Key Manufacturers of Organ-On-Chip Raw Materials
Table 157. Organ-On-Chip Typical Distributors
Table 158. Organ-On-Chip Typical Customers
List of Figures
Figure 1. Organ-On-Chip Picture
Figure 2. Global Organ-On-Chip Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Organ-On-Chip Consumption Value Market Share by Type in 2022
Figure 4. Brain-on-a-chip Examples
Figure 5. Liver-on-a-chip Examples
Figure 6. Kidney-on-a-chip Examples
Figure 7. Lung-on-a-chip Examples
Figure 8. Heart-on-a-chip Examples
Figure 9. Intestine-on-a-chip Examples
Figure 10. Vessel-on-a-chip Examples
Figure 11. Others Examples
Figure 12. Global Organ-On-Chip Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Organ-On-Chip Consumption Value Market Share by Application in 2022
Figure 14. Pharmaceutical & Biotechnology Companies Examples
Figure 15. Academic & Research Institutes Examples
Figure 16. Cosmetics Industry Examples
Figure 17. Others Examples
Figure 18. Global Organ-On-Chip Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 19. Global Organ-On-Chip Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 20. Global Organ-On-Chip Sales Quantity (2018-2029) & (K Units)
Figure 21. Global Organ-On-Chip Average Price (2018-2029) & (US$/Unit)
Figure 22. Global Organ-On-Chip Sales Quantity Market Share by Manufacturer in 2022
Figure 23. Global Organ-On-Chip Consumption Value Market Share by Manufacturer in 2022
Figure 24. Producer Shipments of Organ-On-Chip by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 25. Top 3 Organ-On-Chip Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Top 6 Organ-On-Chip Manufacturer (Consumption Value) Market Share in 2022
Figure 27. Global Organ-On-Chip Sales Quantity Market Share by Region (2018-2029)
Figure 28. Global Organ-On-Chip Consumption Value Market Share by Region (2018-2029)
Figure 29. North America Organ-On-Chip Consumption Value (2018-2029) & (USD Million)
Figure 30. Europe Organ-On-Chip Consumption Value (2018-2029) & (USD Million)
Figure 31. Asia-Pacific Organ-On-Chip Consumption Value (2018-2029) & (USD Million)
Figure 32. South America Organ-On-Chip Consumption Value (2018-2029) & (USD Million)
Figure 33. Middle East & Africa Organ-On-Chip Consumption Value (2018-2029) & (USD Million)
Figure 34. Global Organ-On-Chip Sales Quantity Market Share by Type (2018-2029)
Figure 35. Global Organ-On-Chip Consumption Value Market Share by Type (2018-2029)
Figure 36. Global Organ-On-Chip Average Price by Type (2018-2029) & (US$/Unit)
Figure 37. Global Organ-On-Chip Sales Quantity Market Share by Application (2018-2029)
Figure 38. Global Organ-On-Chip Consumption Value Market Share by Application (2018-2029)
Figure 39. Global Organ-On-Chip Average Price by Application (2018-2029) & (US$/Unit)
Figure 40. North America Organ-On-Chip Sales Quantity Market Share by Type (2018-2029)
Figure 41. North America Organ-On-Chip Sales Quantity Market Share by Application (2018-2029)
Figure 42. North America Organ-On-Chip Sales Quantity Market Share by Country (2018-2029)
Figure 43. North America Organ-On-Chip Consumption Value Market Share by Country (2018-2029)
Figure 44. United States Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Canada Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Mexico Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Europe Organ-On-Chip Sales Quantity Market Share by Type (2018-2029)
Figure 48. Europe Organ-On-Chip Sales Quantity Market Share by Application (2018-2029)
Figure 49. Europe Organ-On-Chip Sales Quantity Market Share by Country (2018-2029)
Figure 50. Europe Organ-On-Chip Consumption Value Market Share by Country (2018-2029)
Figure 51. Germany Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. France Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. United Kingdom Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Russia Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Italy Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Asia-Pacific Organ-On-Chip Sales Quantity Market Share by Type (2018-2029)
Figure 57. Asia-Pacific Organ-On-Chip Sales Quantity Market Share by Application (2018-2029)
Figure 58. Asia-Pacific Organ-On-Chip Sales Quantity Market Share by Region (2018-2029)
Figure 59. Asia-Pacific Organ-On-Chip Consumption Value Market Share by Region (2018-2029)
Figure 60. China Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Japan Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Korea Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. India Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Southeast Asia Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Australia Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. South America Organ-On-Chip Sales Quantity Market Share by Type (2018-2029)
Figure 67. South America Organ-On-Chip Sales Quantity Market Share by Application (2018-2029)
Figure 68. South America Organ-On-Chip Sales Quantity Market Share by Country (2018-2029)
Figure 69. South America Organ-On-Chip Consumption Value Market Share by Country (2018-2029)
Figure 70. Brazil Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Argentina Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Middle East & Africa Organ-On-Chip Sales Quantity Market Share by Type (2018-2029)
Figure 73. Middle East & Africa Organ-On-Chip Sales Quantity Market Share by Application (2018-2029)
Figure 74. Middle East & Africa Organ-On-Chip Sales Quantity Market Share by Region (2018-2029)
Figure 75. Middle East & Africa Organ-On-Chip Consumption Value Market Share by Region (2018-2029)
Figure 76. Turkey Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Egypt Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Saudi Arabia Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. South Africa Organ-On-Chip Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 80. Organ-On-Chip Market Drivers
Figure 81. Organ-On-Chip Market Restraints
Figure 82. Organ-On-Chip Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Organ-On-Chip in 2022
Figure 85. Manufacturing Process Analysis of Organ-On-Chip
Figure 86. Organ-On-Chip Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
